{
    "eid": "2-s2.0-84901487758",
    "title": "Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: A randomized study of immunogenicity and safety",
    "cover-date": "2014-01-01",
    "subject-areas": [
        {
            "$": "Microbiology (medical)",
            "@code": "2726"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pediatrics",
            "@code": "2735"
        }
    ],
    "keywords": [
        "children",
        "immunogenicity",
        "Japanese encephalitis vaccine",
        "phase 3 trial",
        "safety"
    ],
    "authors": [
        "Emmanuel Feroldi"
    ],
    "citedby-count": 30,
    "ref-count": 19,
    "ref-list": [
        "Japanese encephalitis: New options for active immunization",
        "Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).",
        "Protection against Japanese Encephalitis by Inactivated Vaccines",
        "Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case-control study",
        "High stability of yellow fever 17D-204 vaccine: A 12-year restrospective analysis of large-scale production",
        "Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties",
        "Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax- JE) as a live, attenuated vaccine candidate against Japanese encephalitis",
        "Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials",
        "Safety and immunogenicity of a single administration of live-attenuated japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial",
        "Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: Randomized, controlled phase 3 immunogenicity and safety trial",
        "Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children",
        "Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non\u2010zero risk difference or non\u2010unity relative risk",
        "Interval estimation for the difference between independent proportions: Comparison of eleven methods",
        "Two-sided confidence intervals for the single proportion: Comparison of seven methods",
        "Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004",
        null,
        "Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants",
        "Immunizing children aged 9 to 15 months with live attenuated SA14-14-2 Japanese encephalitis vaccine in Thailand.",
        null
    ],
    "affiliation": [
        {
            "affiliation-city": "Lyon",
            "affilname": "Sanofi Pasteur SA",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "affilname": "Khon Kaen University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "Sanofi Pasteur",
            "affiliation-country": "Singapore"
        }
    ],
    "funding": []
}